POS EX

Post-effective Amendment

Protagenic Therapeutics, Inc.new Filed 2017-05-16 Acc 0001437749-17-009351

Documents 1

POS EX Post-effective Amendment , atrn20170515_posex.htm

Around this filing

2017-05-22 8-K Auditor change
2017-05-16 POS EX Post-effective Amendment
2017-05-15 10-Q Quarterly Report
2017-05-12 S-8 Securities Offered to Employees in Benefit Plans

Link to a passage

External

SEC EDGAR (opens in new tab)